HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endoluminal embolization of bilateral atherosclerotic common iliac aneurysms with fibrin tissue glue (Beriplast).

Abstract
The standard surgical approach to nonleaking iliac aneurysms found at repair of a leaking abdominal aortic aneurysm is to minimize the operative risk by repairing the abdominal aorta only. This means that the bypassed iliac aneurysms may have to be repaired later. As this population of patients are usually elderly with coexisting medical problems, interventional radiology is being used to embolize these aneurysms, thus avoiding the morbidity and mortality associated with further general anesthesia and surgery. Various materials and stents have been reported to be effective in the treatment of iliac aneurysms. We report the successful use of endoluminal fibrin tissue glue (Beriplast) to treat two large iliac aneurysms in a patient who had had a previous abdominal aortic aneurysm repair. We discuss the technique involved and the reasons why we used tissue glue in this patient.
AuthorsR C Beese, M A Tomlinson, T M Buckenham
JournalCardiovascular and interventional radiology (Cardiovasc Intervent Radiol) 2000 May-Jun Vol. 23 Issue 3 Pg. 239-41 ISSN: 0174-1551 [Print] United States
PMID10821905 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Fibrin Tissue Adhesive
  • Tissue Adhesives
Topics
  • Aged
  • Aged, 80 and over
  • Aneurysm, Ruptured (diagnostic imaging, therapy)
  • Angiography
  • Arteriosclerosis (complications, therapy)
  • Embolization, Therapeutic (methods)
  • Fibrin Tissue Adhesive
  • Follow-Up Studies
  • Humans
  • Iliac Aneurysm (diagnostic imaging, etiology, therapy)
  • Male
  • Tissue Adhesives

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: